Literature DB >> 16269351

Insulin-like growth factor (IGF) induced proliferation of human lung fibroblasts is enhanced by neurotensin.

Richard C Scarpa1, Robert E Carraway, David E Cochrane.   

Abstract

Fibroblasts are key cells in tissue repair and important contributors to the inflammatory response. Insulin-like growth factors (IGFs) have been shown to participate in growth, in immune responses and in tissue repair where they stimulate cell growth. Neurotensin (NT) has been suggested to participate in inflammation and in tissue repair and is an autocrine or paracrine growth factor for several cancer cell types. Here we show that IGF-induced proliferation of fibroblasts is enhanced by NT in a concentration and type 1 NT-receptor dependent manner. This action of NT was blocked by inhibitors of phospholipase C and protein kinase C but not by inhibitors of phosphoinositide-3-kinase. An inhibitor of MEK 1/2 significantly reduced the proliferative effects of the IGFs but NT's ability to enhance IGF-induced proliferation was not effected. The ability of NT to enhance IGF-induced proliferation did not involve an autocrine factor. These results suggest that interactions between NT and the IGFs may contribute to the regulation of fibroblasts in for example, inflamed or injured tissues.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16269351     DOI: 10.1016/j.peptides.2005.03.044

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  6 in total

1.  HMC-1 human mast cells synthesize neurotensin (NT) precursor, secrete bioactive NT-like peptide(s) and express NT receptor NTS1.

Authors:  David E Cochrane; Robert E Carraway; Kimberly Harrington; Melissa Laudano; Stephen Rawlings; Ross S Feldberg
Journal:  Inflamm Res       Date:  2011-09-17       Impact factor: 4.575

2.  Insulin-like growth factor-II is increased in systemic sclerosis-associated pulmonary fibrosis and contributes to the fibrotic process via Jun N-terminal kinase- and phosphatidylinositol-3 kinase-dependent pathways.

Authors:  Eileen Hsu; Carol A Feghali-Bostwick
Journal:  Am J Pathol       Date:  2008-05-08       Impact factor: 4.307

3.  Insulin-like growth factor-I receptor blockade improves outcome in mouse model of lung injury.

Authors:  Jung-Eun Choi; Sung-Soon Lee; Donald A Sunde; Isham Huizar; Kathy L Haugk; Victor J Thannickal; Ragini Vittal; Stephen R Plymate; Lynn M Schnapp
Journal:  Am J Respir Crit Care Med       Date:  2008-11-14       Impact factor: 21.405

4.  IGF-I induced genes in stromal fibroblasts predict the clinical outcome of breast and lung cancer patients.

Authors:  Michal Rajski; Rosanna Zanetti-Dällenbach; Brigitte Vogel; Richard Herrmann; Christoph Rochlitz; Martin Buess
Journal:  BMC Med       Date:  2010-01-05       Impact factor: 8.775

5.  Epithelial atrophy in oral submucous fibrosis is mediated by copper (II) and arecoline of areca nut.

Authors:  Imran Khan; Ila Pant; Sivakrishna Narra; Rekha Radhesh; Kannan Ranganathan; Somanahalli Girish Rao; Paturu Kondaiah
Journal:  J Cell Mol Med       Date:  2015-08-06       Impact factor: 5.310

6.  Role of IGF-1 pathway in lung fibroblast activation.

Authors:  Chi F Hung; Maryam G Rohani; Sung-Soon Lee; Peter Chen; Lynn M Schnapp
Journal:  Respir Res       Date:  2013-10-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.